Kyverna Therapeutics, Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

8.37

-0.27 (-3.13%)

At close: Aug 28, 2026, 4:00 PM EDT

8.53

+0.16 (1.91%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Kyverna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	31.81	124.09	96.62	34.65	37.74	76.07
Short-Term Investments	167.62	155.16	189.36	22.9	13.59	-
Cash & Short-Term Investments	199.43	279.25	285.98	57.54	51.32	76.07
Cash Growth	-5.79%	-2.35%	396.98%	12.12%	-32.53%	-
Prepaid Expenses	7.02	3.6	4.62	3.12	1.93	1.02
Other Current Assets	0.1	0.1	-	-	-	-
Total Current Assets	206.54	282.95	290.6	60.66	53.25	77.09
Property, Plant & Equipment	9.29	5.42	10.66	10.61	12.44	7.81
Long-Term Deferred Charges	-	-	-	2.5	-	-
Other Long-Term Assets	4	5.45	3.39	1.42	1.23	0.59
Total Assets	219.82	293.83	304.65	75.2	66.92	85.49

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.93	5.31	4.62	4.36	1.45	0.77
Accrued Expenses	18.34	27.21	25.19	9.06	7.66	7.77
Current Portion of Leases	1.53	3.97	3.94	2.92	2.28	0.81
Current Unearned Revenue	-	-	-	-	-	6
Other Current Liabilities	-	-	-	3.52	0.57	0.58
Total Current Liabilities	22.8	36.49	33.76	19.86	11.95	15.93
Long-Term Debt	24.88	24.74	-	-	-	-
Long-Term Leases	6.59	0.32	4.3	6.16	8.29	4.74
Long-Term Unearned Revenue	-	-	-	-	-	1.03
Other Long-Term Liabilities	-	-	-	-	0.01	1.33
Total Liabilities	54.27	61.55	38.06	26.02	20.25	23.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	-	-	-	-
Additional Paid-In Capital	668.56	657.01	530	4.64	1.71	0.53
Retained Earnings	-502.87	-424.83	-263.52	-136.04	-75.68	-46.78
Comprehensive Income & Other	-0.14	0.1	0.11	0	-0.03	-
Total Common Equity	165.55	232.28	266.59	-131.4	-74	-46.25
Shareholders' Equity	165.55	232.28	266.59	49.18	46.68	62.47
Total Liabilities & Equity	219.82	293.83	304.65	75.2	66.92	85.49

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	33	29.03	8.24	9.08	10.56	5.56
Net Cash (Debt)	166.43	250.22	277.74	48.46	40.76	70.51
Net Cash Growth	-19.11%	-9.91%	473.08%	18.91%	-42.20%	-
Net Cash Per Share	3.14	5.65	7.25	71.95	89.48	265.19
Filing Date Shares Outstanding	61.84	60.46	43.21	43.12	0.55	0.27
Total Common Shares Outstanding	61.57	60.39	43.21	1.25	0.55	0.27
Working Capital	183.74	246.47	256.85	40.81	41.3	61.16
Book Value Per Share	2.69	3.85	6.17	-105.11	-133.91	-173.96
Tangible Book Value	165.55	232.28	266.59	-131.4	-74	-46.25
Tangible Book Value Per Share	2.69	3.85	6.17	-105.11	-133.91	-173.96
Machinery	3.39	4.36	6.2	4.17	3.74	3.35
Leasehold Improvements	0.94	0.94	0.82	0.65	0.46	0.08

SEC Filings: 10-K · 10-Q